Exchange: NASDAQ·Updated 07:30 PM EDT

MEDP News

News
all
press releases
Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"
Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.
Zacks
Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"
Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.
Zacks
More News
All You Need to Know About Medpace (MEDP) Rating Upgrade to Buy
Medpace (MEDP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks
Here's Why Medpace (MEDP) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
Medpace Holdings, Inc. Profit Climbs In Q3
(RTTNews) - Medpace Holdings, Inc. (MEDP) revealed earnings for its third quarter that Increased, from the same period last year...
Nasdaq News: Markets
Medpace (MEDP) Q3 Earnings and Revenues Beat Estimates
Medpace (MEDP) delivered earnings and revenue surprises of +8.76% and +1.02%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Medpace Holdings, Inc. Reports Third Quarter 2026 Results
Medpace Holdings, Inc. (Nasdaq: MEDP) (Medpace) today announced financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Financial Results Revenue for the three months ended September 30, 2026 increased 8.5% to $716.0 million, compared to $659.9 million for the...
Business Wire
CON vs. MEDP: Which Stock Should Value Investors Buy Now?
CON vs. MEDP: Which Stock Is the Better Value Option?
Zacks
Medpace (MEDP) Dips More Than Broader Market: What You Should Know
In the latest trading session, Medpace (MEDP) closed at $609.89, marking a -1.64% move from the previous day.
Zacks
Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors
Medpace (MEDP) concluded the recent trading session at $602.9, signifying a -2.84% move from its prior day's close.
Zacks
Medpace Holdings President & CEO Trades $30.32M In Company Stock
August J Troendle, President & CEO at Medpace Holdings (NASDAQ:MEDP), reported an insider sell on October 1, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchangeread more...
Benzinga

Advertisement|Remove ads.